The patients with AD were followed for typically 2.3 years and the non-AD patients were followed for typically 3.4 years. The study found that the incidence of stroke in patients identified as having AD is 1.6 times higher than that of non-AD sufferers. Among the limitations of this study was the shortcoming to assess AD severity. Poster #P3-087: Central Nervous System Comorbidities and Concomitant Drug Make use of in a Medicaid Advertisement Human population This is the first multi-state study to use Medicaid information from 2000-2008 to examine the differences in CNS comorbidities and concomitant drug use and costs.Additional NF VALIDATION studies of the Salmonella assay on seafood and vegetables and also digesting environment samples are anticipated in 2013. Related StoriesPoint-of-treatment diagnostics for EbolaNew programmed-death inhibitor screen assay kit for malignancy research studiesBirmingham experts identify how Salmonella attacks can result in life-threatening thrombosis We're proud to provide this important international validation to our worldwide clients, said Niki Montgomery, 3M Food Safety global marketing manager. It's a big milestone inside our continued work to systematically chart the path toward comprehensive scientific validation.